Alicia R. Berard

Winnipeg, MB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.

Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.

Journal: Microbiology spectrum
Published: March 23, 2026

Identifying a Vaginal Microbiome-Derived Selective Antibiotic Metabolite via Microbiome Pharmacology Analysis.

Identifying a Vaginal Microbiome-Derived Selective Antibiotic Metabolite via Microbiome Pharmacology Analysis.

Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025

Computational microbiome pharmacology analysis elucidates the anti-cancer potential of vaginal microbes and metabolites.

Computational microbiome pharmacology analysis elucidates the anti-cancer potential of vaginal microbes and metabolites.

Journal: Frontiers in microbiology
Published: April 08, 2025

Aging Is Associated With Decreased Lactobacillus and Increased Cervicovaginal Inflammation in Canadian Women.

Aging Is Associated With Decreased Lactobacillus and Increased Cervicovaginal Inflammation in Canadian Women.

Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: October 18, 2024

Computational Microbiome Pharmacology Analysis Elucidates the Anti-Cancer Potential of Vaginal Microbes and Metabolites.

Computational Microbiome Pharmacology Analysis Elucidates the Anti-Cancer Potential of Vaginal Microbes and Metabolites.

Journal: bioRxiv : the preprint server for biology
Published: October 17, 2024

Understanding the Associations of Urogenital Microbiomes With Fertility and In Vitro Fertilization.

Understanding the Associations of Urogenital Microbiomes With Fertility and In Vitro Fertilization.

Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: September 09, 2024

A Description of the THRIVE (The Study of Host-Bacterial Relationships and Immune Function in Different Vaginal Environments) Bacterial Vaginosis Observational Study.

A Description of the THRIVE (The Study of Host-Bacterial Relationships and Immune Function in Different Vaginal Environments) Bacterial Vaginosis Observational Study.

Journal: Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
Published: May 13, 2024

Nonoptimal bacteria species induce neutrophil-driven inflammation and barrier disruption in the female genital tract.

Nonoptimal bacteria species induce neutrophil-driven inflammation and barrier disruption in the female genital tract.

Journal: Mucosal immunology
Published: February 09, 2023

Editorial: Inflammation in the female genital tract.

Editorial: Inflammation in the female genital tract.

Journal: Frontiers in reproductive health
Published: February 08, 2023

Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling.

Vaginal epithelial dysfunction is mediated by the microbiome, metabolome, and mTOR signaling.

Journal: Cell reports
Published: September 29, 2022

Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus.

Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus.

Journal: Microbiome
Published: May 19, 2022

The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine.

The Female Reproductive Tract Microbiome-Implications for Gynecologic Cancers and Personalized Medicine.

Journal: Journal of personalized medicine
Published: April 06, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026